UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Nature medicine, 2022-03, Vol.28 (3), p.486-489

2022

Volltextzugriff (PDF)

Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong

Emerging infectious diseases, 2024-02, Vol.30 (2), p.325-328

2024

Volltextzugriff (PDF)

Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery

Signal transduction and targeted therapy, 2021-04, Vol.6 (1), p.155-155, Article 155

2021

Volltextzugriff (PDF)

Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season – a serological study using retrospective samples collected in Hong Kong

International journal of infectious diseases, 2023-10, Vol.135, p.1-4

2023

Volltextzugriff (PDF)

The N-Terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b Is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus

Journal of virology, 2022-02, Vol.96 (3), p.e0184221

2022

Volltextzugriff (PDF)

Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin

Nature communications, 2024-06, Vol.15 (1), p.5175-12, Article 5175

2024

Volltextzugriff (PDF)

Identification of molecular determinants for the nuclear import of pseudorabies virus UL31

Archives of biochemistry and biophysics, 2015-12, Vol.587, p.12-17

2015

Volltextzugriff (PDF)

Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China

International journal of infectious diseases, 2023-02, Vol.127, p.26-32

2023

Volltextzugriff (PDF)

Tracking the Transcription Kinetic of SARS-CoV-2 in Human Cells by Reverse Transcription-Droplet Digital PCR

Pathogens (Basel), 2021-10, Vol.10 (10), p.1274

2021

Volltextzugriff (PDF)

Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines

Signal transduction and targeted therapy, 2023-09, Vol.8 (1), p.373-373, Article 373

2023

Volltextzugriff (PDF)

Kinetics of viral load and antibody response in relation to COVID-19 severity

The Journal of clinical investigation, 2020-10, Vol.130 (10), p.5235-5244

2020

Volltextzugriff (PDF)

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events

Gut, 2022-06, Vol.71 (6), p.1106

2022

Volltextzugriff (PDF)

A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac

American journal of respiratory and critical care medicine, 2022-04, Vol.205 (7), p.844-847

2022

Volltextzugriff (PDF)

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong

Respirology (Carlton, Vic.), 2022-04, Vol.27 (4), p.301-310

2022

Volltextzugriff (PDF)

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2

Proceedings of the National Academy of Sciences - PNAS, 2023-01, Vol.120 (4), p.e2202820120-e2202820120

2023

Volltextzugriff (PDF)

SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022

Euro surveillance : bulletin européen sur les maladies transmissibles, 2022-05, Vol.27 (18)

2022

Volltextzugriff (PDF)

Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection

Journal of clinical virology, 2022-11, Vol.156, p.105273-105273, Article 105273

2022

Volltextzugriff (PDF)

Neutralizing antibodies against the SARS-CoV-2 Omicron BA.1 variant following homologous and heterologous CoronaVac or BNT162b2 vaccination

Nature medicine, 2022-01, Vol.28 (3), p.486-489

2022

Volltextzugriff (PDF)

Characterization of the nuclear import and export signals of pseudorabies virus UL31

Archives of virology, 2015-10, Vol.160 (10), p.2591-2594

2015

Volltextzugriff (PDF)

Kinetics of viral load and antibody response in relation to COVID-19 severity

The Journal of clinical investigation, 2020-10, Vol.130 (10), p.5235-5244

2020

Volltextzugriff (PDF)

Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study

The Lancet. Microbe, 2023-06, Vol.4 (6), p.e418-e430

2023

Volltextzugriff (PDF)

Probing the nuclear import signal and nuclear transport molecular determinants of PRV ICP22

Cell & bioscience, 2016-01, Vol.6 (5), p.3-3, Article 3

2016

Volltextzugriff (PDF)

Preliminary efficacy of inter-spinal distraction fusion which is a new technique for lumbar disc herniation

International orthopaedics, 2019-04, Vol.43 (4), p.899-907

2019

Volltextzugriff (PDF)

Nutrient retention by different substrates from an improved low impact development system

Journal of environmental management, 2019-05, Vol.238, p.331-340

2019

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)
Tagungsberichte
(1)

Sprache

Englisch
(27)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(19)
Humans
(14)
Covid-19
(11)
Sars-Cov-2
(9)
Severe Acute Respiratory Syndrome Coronavirus 2
(9)
Antibodies
(7)
Covid-19 Vaccines
(7)
Adult
(6)
Biochemistry & Molecular Biology
(6)
Bnt162 Vaccine
(6)
Coronaviruses
(6)
Vaccines
(6)
Animals
(5)
Covid-19 - Prevention & Control
(5)
Female
(5)
Infections
(5)
Antibodies, Neutralizing
(4)
Antibodies, Viral
(4)
Cell Biology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong

Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery

Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season – a serological study using retrospective samples collected in Hong Kong

The N-Terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b Is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus

Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin

Identification of molecular determinants for the nuclear import of pseudorabies virus UL31

Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China

Tracking the Transcription Kinetic of SARS-CoV-2 in Human Cells by Reverse Transcription-Droplet Digital PCR

Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines

Kinetics of viral load and antibody response in relation to COVID-19 severity

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events

A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2

SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022

Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection

Neutralizing antibodies against the SARS-CoV-2 Omicron BA.1 variant following homologous and heterologous CoronaVac or BNT162b2 vaccination

Characterization of the nuclear import and export signals of pseudorabies virus UL31

Kinetics of viral load and antibody response in relation to COVID-19 severity

Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study

Probing the nuclear import signal and nuclear transport molecular determinants of PRV ICP22

Preliminary efficacy of inter-spinal distraction fusion which is a new technique for lumbar disc herniation

Nutrient retention by different substrates from an improved low impact development system

Suchergebnisse filtern